# PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

Study · id `cardio:ct-nct03559114` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03559114](<https://clinicaltrials.gov/study/NCT03559114>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03559114

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1100 participants.

## Technical summary

Registry record NCT03559114. Randomized; triple masking; primary purpose prevention. Start 2018-07-19 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1100 participants (planned count; ClinicalTrials.gov record NCT03559114, source copy `cardio:ctgov-nct03559114-2024-09-19`, retrieved 2026-10-31)
- Started: 2018-07-19 (actual) (ClinicalTrials.gov record NCT03559114, source copy `cardio:ctgov-nct03559114-2024-09-19`, retrieved 2026-10-31)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT03559114, source copy `cardio:ctgov-nct03559114-2024-09-19`, retrieved 2026-10-31)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT03559114, source copy `cardio:ctgov-nct03559114-2024-09-19`, retrieved 2026-10-31)
- Countries: Canada (ClinicalTrials.gov record NCT03559114, source copy `cardio:ctgov-nct03559114-2024-09-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03559114-2024-09-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
- Acronym: PROTEST
- Condition: Traumatic Brain Injury
- Intervention (Drug): Dalteparin
- Intervention (Drug): Saline
- Lead sponsor: Sunnybrook Health Sciences Centre
- Lead sponsor class: OTHER
- Collaborator: Sunnybrook Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry lists this organization as the lead sponsor: Sunnybrook Health Sciences Centre (`cardio:org-sunnybrook-health-sciences-centre`)
- Registry lists this organization as a collaborator: Sunnybrook Research Institute (`cardio:org-sunnybrook-research-institute`)

## Provenance

Content hash: b52ba0e0a6bac61efb32bfaa05c929d7febf450a9ae10575f4b0f8f3b8027fc3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
